Taxanes for breast cancer during pregnancy: A systematic review

Annals of Oncology

Volumn 21, Issue 2, 2010, Pages 425-426

  Mir, O ^a,b,c   Berveiller, P ^c   Goffinet, F ^b,c   Treluyer, J M ^b,c   Serreau, R ^b,c   Goldwasser, F ^a,c   Rouzier, R ^c,d  

^a Teaching Hospital Cochin   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CALG Group French Group of 'Cancers Associés à La Grossesse'   (France)

^d HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; ALOPECIA; ANEMIA; ANHYDRAMNIOS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; DRUG SAFETY; FEMALE; HAND FOOT SYNDROME; HUMAN; HYDRAMNIOS; HYPERBILIRUBINEMIA; INTRAUTERINE GROWTH RETARDATION; LETTER; MAJOR CLINICAL STUDY; MALE; MATERNAL TREATMENT; NAUSEA; NEUTROPENIA; NEWBORN; PREECLAMPSIA; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PYLORUS STENOSIS; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; CHEMICALLY INDUCED DISORDER; EVALUATION; GESTATIONAL AGE; NEOPLASM; NEWBORN DISEASE; PREGNANCY COMPLICATION; PRENATAL EXPOSURE;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL EXPOSURE DELAYED EFFECTS; TAXOIDS;

EID: 77149126251     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp517     Document Type: Letter

References (16)

1. Mir O, Berveiller P, Ropert S et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008; 19: 607-613.
2. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryofetal outcome in 160 patients. Ann Oncol 2004; 15: 146-150.
3. Mir O, Berveiller P, Rouzier R et al. Chemotherapy for breast cancer during pregnancy: is epirubicin safe? Ann Oncol 2008; 19: 1814-1815.
4. Azim HAJr, Scarfone G, Peccatori FA. Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy. J Thorac Oncol 2009; 4: 559-560.
5. Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an International Registry. Am J Clin Oncol 2009 doi: 10.1097/COC.0b013e3181a44ca9.
6. Doi D, Boh Y, Konishi H et al. Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy. Arch Gynecol Obstet 2009; 280: 633-636.
7. Garcia-Gonzalez J, Cueva J, Lamas MJ et al. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy. Clin Transl Oncol 2008; 10: 375-376.
8. Garcia-Manero M, Royo MP, Espinos J et al. Pregnancy associated breast cancer. Eur J Surg Oncol 2009; 35: 215-218.
9. Ibrahim N, Saadeddin A, Al Sabbagh T. TAC chemotherapy during the first trimester of pregnancy-the first case report. J Oncol Pharm Pract 2006; 12: 25.
10. Kim JH, Kim HS, Sung CW et al. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung Cancer 2008; 59: 270-273.
11. Morris PG, King F, Kennedy J. Cytotoxic chemotherapy for pregnancy-associated breast cancer: single institution case series. J Oncol Pharm Pract 2009 doi: 10.1177/1078155209103096.
12. Rouzi AA, Sahly NN, Sahly NF, Alahwal MS. Cisplatinum and docetaxel for ovarian cancer in pregnancy. Arch Gynecol Obstet 2009; 280: 823-825.
13. Mantovani G, Gramignano G, Mais V et al. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur J Obstet Gynecol Reprod Biol 2007; 131: 238-239.
14. Bader AA, Schlembach D, Tamussino KF et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007; 8: 79-81.
15. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanisticbased approach. Clin Pharmacokinet 2005; 44: 989-1008.
16. Lycette JL, Dul CL, Munar M et al. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer 2006; 7: 342-344.